Fortress Biotech (FBIO) Current Taxes (2021 - 2026)
Fortress Biotech (FBIO) posted quarterly Current Taxes of $356000.0 for Q4 2025, down 61.8% year-over-year from $932000.0 in Q4 2024, and down 64.58% quarter-over-quarter from $1.0 million in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Current Taxes (2021 - 2026) Analysis & Trends
Fortress Biotech's Current Taxes history runs 5 years deep, the most recent figure standing at $356000.0 for Q4 2025.
- In Q4 2025, Current Taxes fell 61.8% year-over-year to $356000.0; the TTM figure through Dec 2025 stood at $356000.0 (down 61.8% YoY), while the FY2025 annual figure was $356000.0, down 61.8% from the prior year.
- Current Taxes for Q4 2025 stood at $356000.0, down from $1.0 million in the prior quarter.
- The five-year high for Current Taxes was $1.0 million in Q3 2025, with the low at $84000.0 in Q3 2023.
- The 5-year median for Current Taxes is $764000.0 (2022), against an average of $641937.5.
- The sharpest annual moves came in 2024 and 2025: Current Taxes soared 911.9% in 2024, then slumped 61.8% in 2025.
- Fortress Biotech's Current Taxes stood at $345000.0 in 2021, then jumped by 109.28% to $722000.0 in 2022, then rose by 16.76% to $843000.0 in 2023, then gained by 10.56% to $932000.0 in 2024, then plunged by 61.8% to $356000.0 in 2025.
- Business Quant data shows FBIO's Current Taxes at $356000.0 in Q4 2025, $1.0 million in Q3 2025, and $984000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 5.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.18 Mn |
| Dec 31, 2025 | 356,000.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 984,000.00 |
| Mar 31, 2025 | 952,000.00 |
| Dec 31, 2024 | 932,000.00 |
| Sep 30, 2024 | 850,000.00 |
| Jun 30, 2024 | 806,000.00 |
| Mar 31, 2024 | 843,000.00 |
| Dec 31, 2023 | 843,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Mar 31, 2023 | 722,000.00 |
| Dec 31, 2022 | 722,000.00 |
| Jun 30, 2022 | 345,000.00 |
| Mar 31, 2022 | 346,000.00 |
| Dec 31, 2021 | 345,000.00 |
| Mar 31, 2021 | 136,000.00 |